Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $16.3 million.

  • Onconetix's Total Current Liabilities fell 606.75% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year decrease of 606.75%. This contributed to the annual value of $18.3 million for FY2024, which is 639.83% up from last year.
  • As of Q3 2025, Onconetix's Total Current Liabilities stood at $16.3 million, which was down 606.75% from $12.7 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Total Current Liabilities ranged from a high of $21.4 million in Q1 2024 and a low of $2.8 million during Q1 2023
  • Moreover, its 3-year median value for Total Current Liabilities was $17.2 million (2023), whereas its average is $15.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 66314.01% in 2024, then plummeted by 3839.81% in 2025.
  • Over the past 3 years, Onconetix's Total Current Liabilities (Quarter) stood at $17.2 million in 2023, then rose by 6.4% to $18.3 million in 2024, then fell by 10.86% to $16.3 million in 2025.
  • Its last three reported values are $16.3 million in Q3 2025, $12.7 million for Q2 2025, and $14.0 million during Q1 2025.